Viranz 600mg Tablet

Viranz 600mg Tablet contains an active component called Efavirenz. It is a medication used to treat HIV (human immunodeficiency virus) infection. It is primarily used to treat HIV (human immunodeficiency virus) infection, specifically as part of antiretroviral therapy (ART). It is indicated for use in patients who have already received treatment for HIV or as part of initial therapy for those who have not yet received treatment. It is typically used in combination with other antiretroviral medications, such as nucleoside reverse transcriptase inhibitors (NRTIs) or protease inhibitors, to effectively control HIV infection and prevent the progression to AIDS (acquired immunodeficiency syndrome).

Individuals with known hypersensitivity or allergy to Viranz 600mg Tablet or any of the other components of the medication should not use it. It is not recommended for use during pregnancy, especially during the first trimester, as it may cause harm to the developing fetus. This medication is metabolized in the liver, and individuals with severe liver impairment may experience worsened liver function. Therefore, caution should be exercised when administering it to patients with severe liver problems.  Individuals with a history of severe mental health conditions should be closely monitored, and alternative treatments may be considered. Consult with a healthcare provider before taking Viranz 600mg Tablet, especially if you are an older adult. It may be prescribed for children, but a healthcare provider should determine the dosage and usage based on the child's specific condition and needs.